This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Hessman, O. Articles by Westin, G. Search for Related Content PubMed PubMed Citation Articles by Hessman, O. Articles by Westin, G.

Mutation of the Multiple Endocrine Neoplasia Type 1 Gene in Nonfamilial, Malignant Tumors of the Endocrine Pancreas¹

Departments of Surgery [O. H., D. L., T. C., P. H., J. R., G. Å., G. W.] and Internal Medicine [B. S.], University Hospital, S-751 85 Uppsala, Sweden

Endocrine pancreatic tumors are rare neoplasms that occur sporadically or as part of a multiple endocrine neoplasia type 1 (MEN1) syndrome. Germ-line mutations of the MEN1 gene, located at 11q13, have been demonstrated in MEN1 kindreds, and loss of heterozygosity (LOH) on 11q13 together with somatic MEN1 mutations have been detected in 20% of nonfamilial parathyroid tumors. Here, we examine 11 non-MEN1 malignant tumors of the endocrine pancreas, 9 nonfunctioning tumors, and 2 glucagonomas. LOH of at least one informative locus on 11q13 was found in 70% of the tumors. Three tumors displayed somatic mutations of the MEN1 gene together with LOH on 11q13, whereas the corresponding germ-line DNA was normal. These findings support the hypothesis that MEN1 gene mutations contribute to the tumorigenesis of nonfamilial, malignant endocrine pancreatic tumors.

¹ This work was supported by grants from the Swedish Medical Research Council, the Swedish Cancer Society, the Torsten and Ragnar Söderbergs Research Foundation, and Lions Fund for Cancer Research. Primers for LOH analysis were provided by the Dept. of Clinical Genetics, Uppsala University supported by the Council of the Nordic Ministers and the Swedish Medical Research Council.

² O. H. and D. L. contributed equally to this work.

³ To whom requests for reprints should be addressed. Fax: 46-18-553601; E-mail: ola.hessman@kirurgi.uu.se.

Received 10/13/97. Accepted 12/19/97.

This article has been cited by other articles:

				J. R. LOPEZ-EGIDO, Y. WANG, M. GRONBERG, P. GRIMFJARD, S. WANG, P. STALBERG, and B. SKOGSEID Differentially Regulated Genes in MEN1-transfected BON Cells Using RT-differential Display and Oligonucleotide Microarrays Anticancer Res, June 1, 2009; 29(6): 1859 - 1866. [Abstract] [Full Text] [PDF]

				L. E. MacConaill, C. M. Hughes, O. Rozenblatt-Rosen, S. Nannepaga, and M. Meyerson Phosphorylation of the Menin Tumor Suppressor Protein on Serine 543 and Serine 583 Mol. Cancer Res., October 1, 2006; 4(10): 793 - 801. [Abstract] [Full Text] [PDF]

				P. C. Scacheri, A. L. Kennedy, K. Chin, M. T. Miller, J. G. Hodgson, J. W. Gray, S. J. Marx, A. M. Spiegel, and F. S. Collins Pancreatic Insulinomas in Multiple Endocrine Neoplasia, Type I Knockout Mice Can Develop in the Absence of Chromosome Instability or Microsatellite Instability Cancer Res., October 1, 2004; 64(19): 7039 - 7044. [Abstract] [Full Text] [PDF]

				V. Busygina, K. Suphapeetiporn, L. R. Marek, R. S. Stowers, T. Xu, and A. E. Bale Hypermutability in a Drosophila model for multiple endocrine neoplasia type 1 Hum. Mol. Genet., October 1, 2004; 13(20): 2399 - 2408. [Abstract] [Full Text] [PDF]

				P. Stalberg, P. Grimfjard, M. Santesson, Y. Zhou, D. Lindberg, A. Gobl, K. Oberg, G. Westin, J. Rastad, S. Wang, et al. Transfection of the Multiple Endocrine Neoplasia Type 1 Gene to a Human Endocrine Pancreatic Tumor Cell Line Inhibits Cell Growth and Affects Expression of JunD, {delta}-Like Protein 1/Preadipocyte Factor-1, Proliferating Cell Nuclear Antigen, and QM/Jif-1 J. Clin. Endocrinol. Metab., May 1, 2004; 89(5): 2326 - 2337. [Abstract] [Full Text] [PDF]

				T. M. Shattuck, J. Costa, M. Bernstein, R. T. Jensen, D. C. Chung, and A. Arnold Mutational Analysis of Smad3, a Candidate Tumor Suppressor Implicated in TGF-{beta} and Menin Pathways, in Parathyroid Adenomas and Enteropancreatic Endocrine Tumors J. Clin. Endocrinol. Metab., August 1, 2002; 87(8): 3911 - 3914. [Abstract] [Full Text] [PDF]

				S. S. Guo and M. P. Sawicki Molecular and Genetic Mechanisms of Tumorigenesis in Multiple Endocrine Neoplasia Type-1 Mol. Endocrinol., October 1, 2001; 15(10): 1653 - 1664. [Abstract] [Full Text] [PDF]

				A. A. J. Pannett and R. V. Thakker Somatic Mutations in MEN Type 1 Tumors, Consistent with the Knudson ""Two-Hit"" Hypothesis J. Clin. Endocrinol. Metab., September 1, 2001; 86(9): 4371 - 4374. [Abstract] [Full Text] [PDF]

				O. Hessman, B. Skogseid, G. Westin, and G. Åkerström Multiple Allelic Deletions and Intratumoral Genetic Heterogeneity in MEN1 Pancreatic Tumors J. Clin. Endocrinol. Metab., March 1, 2001; 86(3): 1355 - 1361. [Abstract] [Full Text]

				G. Rigaud, E. Missiaglia, P. S. Moore, G. Zamboni, M. Falconi, G. Talamini, A. Pesci, A. Baron, D. Lissandrini, G. Rindi, et al. High Resolution Allelotype of Nonfunctional Pancreatic Endocrine Tumors: Identification of Two Molecular Subgroups with Clinical Implications Cancer Res., January 1, 2001; 61(1): 285 - 292. [Abstract] [Full Text]

				J. Serrano, S. U. Goebel, P. L. Peghini, I. A. Lubensky, F. Gibril, and R. T. Jensen Alterations in the p16INK4a/CDKN2A Tumor Suppressor Gene in Gastrinomas J. Clin. Endocrinol. Metab., November 1, 2000; 85(11): 4146 - 4156. [Abstract] [Full Text]

				S. U. Goebel, C. Heppner, A. L. Burns, S. J. Marx, A. M. Spiegel, Z. Zhuang, I. A. Lubensky, F. Gibril, R. T. Jensen, and J. Serrano Genotype/Phenotype Correlation of Multiple Endocrine Neoplasia Type 1 Gene Mutations in Sporadic Gastrinomas J. Clin. Endocrinol. Metab., January 1, 2000; 85(1): 116 - 123. [Abstract] [Full Text]

				B. Gortz, J. Roth, A. Krahenmann, R. R. de Krijger, S. Muletta-Feurer, K. Rutimann, P. Saremaslani, E. J. M. Speel, P. U. Heitz, and P. Komminoth Mutations and Allelic Deletions of the MEN1 Gene Are Associated with a Subset of Sporadic Endocrine Pancreatic and Neuroendocrine Tumors and Not Restricted to Foregut Neoplasms Am. J. Pathol., February 1, 1999; 154(2): 429 - 436. [Abstract] [Full Text] [PDF]

				M. D. Mailman, P. Muscarella, W. J. Schirmer, E. C. Ellison, T. M. O'Dorisio, and T. W. Prior Identification of MEN1 Mutations in Sporadic Enteropancreatic Neuroendocrine Tumors by Analysis of Paraffin-embedded Tissue Clin. Chem., January 1, 1999; 45(1): 29 - 34. [Abstract] [Full Text] [PDF]